テストステロン補充療法市場- 世界の産業規模、シェア、動向、機会、予測、適応症別、製品タイプ別、薬効別、流通チャネル別、地域別、競合別、2020-2030年

テストステロン補充療法の世界市場は、2024年に5億8,726万米ドルと評価され、2030年には9億4,753万米ドルに達すると予測され、予測期間中のCAGRは8.30%で拡大すると予測されています。

テストステロン補充療法（TRT）は、テストステロン欠乏症または性腺機能低下症と診断された人を治療するために考案された医療介入です。この病態は加齢男性に多くみられ、疲労、筋肉量の減少、性欲減退、気分の変動などの症状を引き起こす可能性があります。TRTは通常、徹底的な医学的評価とホルモンレベルの評価から始まり、オーダーメイドの治療計画が続きます。テストステロン欠乏症とその男性の健康への影響に対する認識の高まりに加え、局所用ゲル、長時間作用型注射剤、頬錠剤など、より簡便な送達方法の開発が市場の成長を後押ししています。さらに、高齢化社会と個別化ヘルスケアの台頭が、TRTの需要拡大に重要な役割を果たしています。

市場促進要因

ドラッグデリバリーの進歩

市場の課題

偏見と誤解

主な市場動向

カスタマイズされた治療計画

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のテストステロン補充療法市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 適応症別（自己免疫疾患、遺伝性疾患、性腺機能低下症、性器手術）
  • 製品タイプ別（口腔内接着剤、ジェルまたはクリーム、インプラント、経口、非経口、パッチ）
  • 有効成分（メチルテストステロン、テストステロンシピオネート、テストステロンエナント酸エステル）
  • 流通チャネル別（病院薬局、オンライン薬局、小売薬局）
  • 国別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域のテストステロン補充療法市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のテストステロン補充療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のテストステロン補充療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のテストステロン補充療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのテストステロン補充療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のテストステロン補充療法市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• AbbVie Inc.
• Bausch Health Companies Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Cipla Limited
• Sun Pharmaceuticals Industries Ltd.
• Johnsons & Johnsons Services Inc
• Sanofi SA
• GSK Plc.
• Pfizer Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Testosterone Replacement Therapy Market was valued at USD 587.26 Million in 2024 and is anticipated to reach USD 947.53 Million by 2030, expanding at a CAGR of 8.30% during the forecast period. Testosterone Replacement Therapy (TRT) is a medical intervention designed to treat individuals diagnosed with testosterone deficiency or hypogonadism. This condition, more prevalent in aging men, can lead to symptoms such as fatigue, reduced muscle mass, decreased libido, and mood fluctuations. TRT typically begins with thorough medical assessments and hormone level evaluations, followed by tailored treatment plans. Increased awareness of testosterone deficiency and its impact on men's health, along with the development of more convenient delivery methods-including topical gels, long-acting injectables, and buccal tablets-has fueled market growth. Additionally, the aging population and rise of personalized healthcare have played a critical role in the growing demand for TRT.

Key Market Drivers

Advancements in Drug Delivery

Recent innovations in drug delivery systems have significantly improved the efficacy and convenience of Testosterone Replacement Therapy. Transdermal patches are favored for their consistent hormone release and discreet application on the skin. Topical gels, like AndroGel and Testim, are easily applied and allow flexible dosing. Buccal tablets, placed between the gum and cheek, offer a non-invasive alternative for those avoiding injections. Long-acting injectables, such as testosterone undecanoate, require less frequent administration-every 8 to 12 weeks-enhancing patient compliance. Testosterone pellets, implanted subcutaneously, provide long-term hormone delivery with minimal maintenance. Nasal gel formulations and emerging micro-needle patches offer additional non-invasive methods for testosterone administration. Furthermore, implantable devices under development aim to deliver continuous hormone release over extended periods. With telemedicine integration, patients now have easier access to consultations and prescriptions, improving adherence and broadening the market's reach.

Key Market Challenges

Stigma and Misconceptions

The market faces challenges stemming from societal stigma and misunderstandings surrounding TRT. A common misconception is that TRT is predominantly used for athletic performance enhancement, overshadowing its legitimate use in medically diagnosed hypogonadism. Negative associations with steroid abuse in sports further fuel skepticism and distrust. Additionally, overpromotion of "Low T" symptoms in media campaigns has raised concerns about overdiagnosis and inappropriate prescriptions. Fears surrounding side effects and perceived risks can discourage both patients and physicians from considering TRT. Cultural attitudes linking testosterone deficiency to diminished masculinity may prevent men from seeking help, reinforcing feelings of embarrassment. Moreover, insufficient knowledge among both healthcare providers and the public can lead to hesitancy or misinformation about the therapy's effectiveness and safety.

Key Market Trends

Customized Treatment Plans

Customized treatment plans are becoming central to Testosterone Replacement Therapy, emphasizing individualized, patient-centric approaches. These plans involve comprehensive evaluations to determine the optimal dosage and method of administration based on each patient's hormone levels, symptoms, and medical history. Ongoing monitoring ensures that treatment remains both effective and safe, allowing timely adjustments to dosage or delivery method. Healthcare providers also assess other health factors, such as cardiovascular and prostate health, to mitigate risks. Lifestyle aspects-such as diet, sleep, exercise, and stress-are increasingly integrated into treatment strategies to maximize results. Patients are actively engaged in their care decisions, selecting preferred delivery options like gels, injections, patches, or buccal tablets, which enhances satisfaction and treatment adherence. The growing emphasis on personalization reflects broader trends in modern medicine and supports better health outcomes.

Key Market Players

• AbbVie Inc.
• Bausch Health Companies Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Cipla Limited
• Sun Pharmaceuticals Industries Ltd.
• Sanofi SA
• Johnsons & Johnsons Services Inc
• GSK Plc.

Report Scope:

In this report, the Global Testosterone Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Testosterone Replacement Therapy Market, By Indication:

• Autoimmune Conditions
• Genetic Disorders
• Hypogonadism
• Sex Organ Surgeries

Testosterone Replacement Therapy Market, By Product Type:

• Buccal Adhesive
• Gel or Creams
• Implants
• Oral
• Parenteral
• Patches

Testosterone Replacement Therapy Market, By Drug Active:

• Methyltestosterone
• Testosterone Cypionate
• Testosterone Enanthate

Testosterone Replacement Therapy Market, By Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Testosterone Replacement Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Testosterone Replacement Therapy Market.

Available Customizations:

Global Testosterone Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Testosterone Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism, Sex Organ Surgeries)
  • 5.2.2. By Product Type (Buccal Adhesive, Gel or Creams, Implants, Oral, Parenteral, Patches)
  • 5.2.3. By Drug Active (Methyltestosterone, Testosterone Cypionate, Testosterone Enanthate)
  • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
  • 5.2.5. By Country
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Testosterone Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Product Type
  • 6.2.3. By Drug Active
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Testosterone Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Drug Active
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. India Testosterone Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Drug Active
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Australia Testosterone Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Drug Active
      • 6.3.3.2.4. By Distribution Channel
  • 6.3.4. Japan Testosterone Replacement Therapy Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Indication
      • 6.3.4.2.2. By Product Type
      • 6.3.4.2.3. By Drug Active
      • 6.3.4.2.4. By Distribution Channel
  • 6.3.5. South Korea Testosterone Replacement Therapy Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Indication
      • 6.3.5.2.2. By Product Type
      • 6.3.5.2.3. By Drug Active
      • 6.3.5.2.4. By Distribution Channel

7. Europe Testosterone Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Product Type
  • 7.2.3. By Drug Active
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Testosterone Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Drug Active
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Testosterone Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Drug Active
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. Spain Testosterone Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Drug Active
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Testosterone Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Indication
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Drug Active
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. United Kingdom Testosterone Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Drug Active
      • 7.3.5.2.4. By Distribution Channel

8. North America Testosterone Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Product Type
  • 8.2.3. By Drug Active
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Testosterone Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Drug Active
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. Mexico Testosterone Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Drug Active
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Canada Testosterone Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Drug Active
      • 8.3.3.2.4. By Distribution Channel

9. South America Testosterone Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Product Type
  • 9.2.3. By Drug Active
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Testosterone Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Drug Active
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Testosterone Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Drug Active
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Testosterone Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Drug Active
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Testosterone Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Indication
  • 10.2.2. By Product Type
  • 10.2.3. By Drug Active
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Testosterone Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Indication
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Drug Active
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Testosterone Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Indication
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Drug Active
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Testosterone Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Indication
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Drug Active
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Testosterone Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. AbbVie Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Bausch Health Companies Inc.
• 16.3. Teva Pharmaceutical Industries Ltd.
• 16.4. Perrigo Company plc
• 16.5. Cipla Limited
• 16.6. Sun Pharmaceuticals Industries Ltd.
• 16.7. Johnsons & Johnsons Services Inc
• 16.8. Sanofi SA
• 16.9. GSK Plc.
• 16.10.Pfizer Inc.

17. Strategic Recommendations

18. About Us & Disclaimer